as on December 23, 2025 at 4:01 pm IST
Day's Low
Day's High
1.30%
Downside
0.68%
Upside
52 Week's Low
52 Week's High
56.58%
Downside
9.92%
Upside
as on December 23, 2025 at 4:01 pm IST
Market Cap
₹259.39 Cr
Return on Equity (ROE)
1.24
PE Ratio (TTM)
0Return on capital employed (ROCE)
2.99
Beta (LTM)
0.77
P/B Ratio
2.42
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
20
EPS (TTM)
0Sector
Healthcare
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Lotus Eye Hospital & Institute Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 259.39 | 58.45% | 0.00 | 2 | 49 | |
| NA | 2,762.25 | 122.46% | 0.00 | 41 | 318 | |
| NA | 27.11 | -16.69% | 0.00 | 1 | 24 | |
| NA | 2,167.32 | 18.37% | 0.67 | 1 | 1,086 | |
| NA | 198.32 | -5.27% | 0.00 | 3 | 22 |
Get share price movements and forecasts by analysts on Lotus Eye Hospital & Institute Ltd.
Source: S&P Global Market Intelligence
Search interest for Lotus Eye Hospital & Institute Ltd Stock has increased by 32% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:32% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Lotus Eye Hospital & Institute Ltd.
Lotus Eye Hospital & Institute Ltd’s net profit jumped 20% since last year same period to ₹0.12Cr in the Q2 2025-2026. On a quarterly growth basis, Lotus Eye Hospital & Institute Ltd has generated -77.78% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2023, Lotus Eye Hospital & Institute Ltd has declared dividend of ₹0.50 per share on 24 May 2023 - translating a dividend yield of 0.80%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Up
![]()
Promoters have increased holdings from 40.39% to 40.64% in Sep 2025 quarter
Best in 1 Year
![]()
In the last 1 year, LOTUSEYE has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
Price Rise
![]()
In the last 1 month, LOTUSEYE stock has moved up by 18.8%
Against Peers
![]()
In the last 3 years, Fortis Healthcare Ltd has given 235.9% return, outperforming this stock by 180.5%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 59.58% to 59.33% in Sep 2025 quarter
| Organisation | Lotus Eye Hospital & Institute Ltd |
| Industry | Healthcare |
| CEO | Kaveetha Sundaramoorthy |
| E-voting on shares | Click here to vote |
Lotus Eye Hospital & Institute Ltd share price today stands at ₹126.64 as on at the close of the market. Lotus Eye Hospital & Institute Ltd share today touched a day high of ₹127.5 and a low of ₹125.
Lotus Eye Hospital & Institute Ltd touched a 52 week high of ₹139.2 and a 52 week low of ₹54.99. Lotus Eye Hospital & Institute Ltd share price today i.e. is closed at ₹126.64, which is -9.02% down from its 52 week high and 130.30% up from its 52 week low.
Lotus Eye Hospital & Institute Ltd market capitalisation is ₹259.39 Cr as on .
To buy Lotus Eye Hospital & Institute Ltd shares, you need to follow these steps:
Lotus Eye Hospital & Institute Ltd trading volume is 9,240.00 as on . This means that 9,240.00 shares of Lotus Eye Hospital & Institute Ltd were bought and sold on the stock market during today's trading session.